February 2014: Oversubscribed – Capital increase successful
The capital increase of InnoMedica by 49,000 shares / CHF 655’500 was successfully completed with oversubscription.
We are very pleased with the interest in our company as well as our project and want to give the 40 new shareholders a warm welcome at InnoMedica. Further, we are delighted with the subscribtion of new shares by existing shareholders, which have reinforced their commitment. This is consistent with our strategy to consider also smaller shareholders and to achieve our goal with a broad shareholder base. An average of over 1,400 shares per investor were subscribed.
The allocation of shares by the Board of InnoMedica has already been decided and will be announced in the coming days to the shareholders.